AIP
EDIT icon

Ahrens Investment Partners’s Editas Medicine EDIT Stock Holding History

Ahrens Investment Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$2.31K Buy
+318
New +$2.83K ﹤0.01% 871
2022
Q3 		– Sell
-393
Closed -$5K – 372
2022
Q2 		$5K Buy
393
+78
+25% +$1.04K ﹤0.01% 766
2022
Q1 		$6K Sell
315
-885
-74% -$16.4K ﹤0.01% 821
2021
Q4 		$32K Buy
+1,200
New +$41.3K 0.01% 492

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Ahrens Investment Partners's EDIT Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in Editas Medicine (EDIT) in Q1 2023: 318 shares worth $2.31K. The stake represents ﹤0.01% of the portfolio and ranks #871 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in EDIT as recently as Q2 2022.

Ahrens Investment Partners first reported a position in EDIT in Q4 2021 and has held it in 4 quarters since. The position peaked at $32K in Q4 2021. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

  • Ahrens Investment Partners held 318 shares of Editas Medicine worth $2.31K as of Q1 2023.
  • Editas Medicine was a new Ahrens Investment Partners position in Q1 2023.
  • Editas Medicine made up ﹤0.01% of Ahrens Investment Partners's portfolio in Q1 2023, its #871 holding.
  • Ahrens Investment Partners first reported a position in Editas Medicine in Q4 2021 and has held it in 4 quarters since.
  • Ahrens Investment Partners's Editas Medicine position peaked at $32K in Q4 2021.
  • 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.